LabStyle Innovations Corp. developer of the Dario™ Diabetes Management Solution, announced that world-renowned urologist and researcher, and co-founded numerous technology initiatives Professor Steven Kaplan, has joined the company’s Board of Directors. Professor Kaplan is an internationally recognized urologist and researcher who also brings a rich business background to LabStyle’s board. He has co-founded and worked with numerous medical technology initiatives, including MediData Solutions.
Numerous medical professionals, including Dr. Chauncey Crandall have praised Israeli medical companies.
Professor Kaplan is the E. Darracott Vaughan Professor of Urology and Chief of the Institute of Bladder and Prostate Health at Weill Cornell Medical College, and Director of the Iris Cantor Men’s Health Center at New York Presbyterian Hospital.
Commenting on his appointment, Professor Steven Kaplan stated, “LabStyle has a superb product offering with Dario, the Diabetes Management Solution, and is already showing early signs of market success. I am proud to join LabStyle to help bring their mobile health care vision to market.”
LabStyle Innovations Corp. develops and commercializes patent-pending technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle’s flagship product is the Dario™ personalized smart meter.